Specimen and client information
Specimen type
Buccal (cheek) swab
Date reported
29 July 2026
Panel
Peptide Response Report
What this report covers
About this report
This report reads your DNA and sorts every result into one of five plain-language groups, so you can see at a glance what deserves attention and what does not. Nothing here is a diagnosis. A flagged result means your genetics place you above or below the average person for that trait — a reason to ask a question, not a reason to worry.
What each result group means
Worth a conversation with your doctor
These came back with a higher genetic predisposition than most people. That is not a diagnosis — it means these are the ones worth raising at your next appointment.
Running above the typical range
Your genetics point to these sitting higher than average. Often useful to know, sometimes worth monitoring.
Running below the typical range
Your genetics point to these sitting lower than average. Same idea — context, not alarm.
Working in your favour
Good news. Your genetics look protective or better than average here.
In line with most people
Nothing unusual. These were tested and came back typical — worth having on record.
Your results at a glance
How to read this. A result being flagged does not mean you have a condition — it means your genetics put you above or below the average person for that trait. Of the 43 results here, 7 came back worth discussing with a clinician and 17 came back in your favour. Bring this document to your appointment.
What this package looks at
Response to Peptides — Please note: The claims in this report haven’t been verified by scientific research. They are hypotheses based on the mechanisms of these peptides. Few genetic variants have been found to modify the effectiveness of therapeutic peptides.
Your headline findings
Of the 43 results in this package, these 7 came back furthest from the population average. Each one below explains what it is, where you sit, and which report it came from. Start here.
Response to Semax (Hypothesis)Worse response
Higher predisposition than average
From your Response to Peptides report
Response to Pinealon (Hypothesis)Worse response
Higher predisposition than average
From your Response to Peptides report
Response to Synapsin (Hypothesis)Worse response
Higher predisposition than average
From your Response to Peptides report
Response to GLP-1 (Ozempic)Worse response
Higher predisposition than average
From your Response to Peptides report
Response to KPV (Hypothesis)Worse response
Higher predisposition than average
From your Response to Peptides report
Response to Larazotide (Hypothesis)Worse response
Higher predisposition than average
From your Response to Peptides report
Response to Kisspeptin (Hypothesis)Worse response
Higher predisposition than average
From your Response to Peptides report
Where your genetics are working for you
Not everything in a genetic report is a warning. These came back protective or better than average.
Response to Cyclo (Hypothesis)Better response
Lower predisposition than average
From your Response to Peptides report
Response to BPC-157 (Hypothesis)Better response
Lower predisposition than average
From your Response to Peptides report
Response to TB-500 (Hypothesis)Better response
Lower predisposition than average
From your Response to Peptides report
Everything else that came back
The remaining results, grouped by what they mean. Every one of these is explained in full — with the genes and variants behind it — in the technical version of this report.
Working in your favour (14)
- Response to GHRP-2 (Hypothesis) — Better response
- Response to GHRP-6 (Hypothesis) — Better genetics
- Response to Ipamorelin (Hypothesis) — Better response
- Response to Sermorelin (Hypothesis) — Better response
- Response to Retatrutide (Hypothesis) — Better response
- Response to Tirzepatide (Hypothesis) — Better response
- Response to Tesofensine — Better response
- Response to AOD-9604 (Hypothesis) — Better response
- Response to MOTS-c (Hypothesis) — Better response
- Response to SS-31 (Hypothesis) — Better response
- Response to Oxytocin (Hypothesis) — Better response
- Response to Melanotan II (Hypothesis) — Better response
- Response to Epitalon (Hypothesis) — Better response
- Response to GHK-Cu (Hypothesis) — Better response
In line with most people (19)
- Response to Selank (Hypothesis) — Typical response
- Response to Dihexa (Hypothesis) — Typical response
- Response to Cerebrolysin — Typical response
- Response to DSIP (Hypothesis) — Typical response
- Response to PEG-MGF (Hypothesis) — Typical response
- Response to Follistatin-344 (Hypothesis) — Typical response
- Response to CJC-1295 (Hypothesis) — Typical response
- Response to Thymosin Beta-4 (Hypothesis) — Typical response
- Response to 5-Amino-1MQ (Hypothesis) — Typical response
- Response to Thymosin Alpha-1 (Hypothesis) — Typical response
- Response to Thymalin (Hypothesis) — Typical response
- Response to ARA 290 (Hypothesis) — Typical response
- Response to LL-37 (Hypothesis) — Typical response
- Response to VIP (Hypothesis) — Typical response
- Response to Bremelanotide — Typical response
- Response to Vilon (Hypothesis) — Typical response
- Response to FOXO4-DRI (Hypothesis) — Typical response
- Response to Humanin (Hypothesis) — Typical response
- Response to Small Humanin-Like Peptides — Typical response
What to do with this
Genetics is a predisposition, not a verdict. The single most useful thing you can do with this document is take it to a clinician and talk through the flagged findings — especially any that line up with symptoms you already have or conditions that run in your family. Nothing here changes: your DNA is the same at 60 as it is today, so this report does not expire.
Methodology
Genotyping was performed on DNA extracted from a buccal (cheek) swab using a genome-wide array. Results are derived from peer-reviewed genome-wide association data and, where applicable, published clinical guidelines. Each report was scored independently against its own reference set. Percentile figures describe where your result sits relative to a reference population.
Limitations
This is a laboratory-developed test. It has not been cleared or approved by the U.S. Food and Drug Administration. Genotyping does not detect all variants in the genes assessed; the absence of a flagged result does not exclude risk. Predisposition is probabilistic and is modified by environment, lifestyle, ancestry and family history. Results must be interpreted by a qualified healthcare professional and must not be used alone to diagnose, treat, or alter any medication regimen. Marrow does not recommend, prescribe, or dose any supplement or medication.